62: A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England. (January 2017)

• Record Type: Journal Article
• Authors: Yip, K.; Conibear, J.; Woolf, D.; Tarver, K.; Willis, B.; Hall, S.; Sun, F.; Kuhan, H.; Lambourne, B.; Piskilidis, P.; Kussaibati, R.; Martin, L.; Satar, N. Abdul; Gray, C.M.N.; Khan, A.; Doherty, G.; Prewett, S.; Smith, M.; Dancey, G.; Patterson, D.M.; Rimmer, Y.; Hollingdale, A.; Ingle, C.; Tasigiannopoulos, Z.; Aslam, S.; Waite, K.; Polychronis, A.; Ghafoor, Q.; Baijal, S.; Newsom-Davis, T.; Shah, R.; Forster, M.; Mulatero, C.; Greystoke, A.; Postmus, P.E.; Blackhall, F.; Gilligan, D.;
• Is Part Of: Lung cancer. Volume 103(2017)Supplement 1
• Page Start: S28
• Page End: S29
• Publication Date: 2017-01
• Subjects: Lungs -- Cancer -- Periodicals; Lung Neoplasms -- Abstracts; Lung Neoplasms -- Periodicals; Poumons -- Cancer -- Périodiques; Lungs -- Cancer; Periodicals; Electronic journals; Electronic journals; 616.99424
• DOI: 10.1016/S0169-5002(17)30112-5
• Languages: English
• ISSNs: 0169-5002